These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2886245)

  • 1. The effect of various dose regimens of famotidine on basal nocturnal and meal-stimulated gastric secretion.
    Ryan JR; Chremos AN; Vargas R; Mantell G; Johnson CL; McMahon FG
    Clin Pharmacol Ther; 1987 Aug; 42(2):225-31. PubMed ID: 2886245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of oral and intravenous famotidine on inhibition of nocturnal gastric acid secretion.
    Ryan JR; Vargas R; McMahon FG; Chremos AN
    Am J Med; 1986 Oct; 81(4B):60-4. PubMed ID: 2877576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
    Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
    Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
    Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of famotidine.
    Smith JL
    Digestion; 1985; 32 Suppl 1():15-23. PubMed ID: 2866132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
    J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of famotidine: a summary.
    Chremos AN
    J Clin Gastroenterol; 1987; 9 Suppl 2():7-12. PubMed ID: 2887616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 24-hour acid suppression profile of nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
    Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients.
    Brozinsky S; Hogan DL; Isenberg JI; Richardson CT
    Dig Dis Sci; 1984 Feb; 29(2):129-33. PubMed ID: 6141898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing.
    McCullough AJ; Graham DY; Knuff TE; Lanza FL; Levenson HL; Lyon DT; Munsell WP; Perozza J; Roufail WM; Sinar DR
    Gastroenterology; 1989 Oct; 97(4):860-6. PubMed ID: 2570730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human acid secretion during daily administration of H2-blockers].
    Müller P; Simon B; Dammann HG; Feurle G; Lichtwald K; Schmidt-Gayk H
    Schweiz Med Wochenschr; 1984 May; 114(19):667-71. PubMed ID: 6330886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17).
    Zimmerhackl B; Wünsch E; Classen M; Schusdziarra V; Schepp W
    Regul Pept; 1993 Jul; 46(3):583-92. PubMed ID: 8105512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
    Fukuda Y; Ikezoe I; Okabayashi M; Ohama I; Shimoyama T
    Clin Ther; 1987; 9(5):528-35. PubMed ID: 2889528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.
    Savarino V; Mela GS; Scalabrini P; Fera G; Zentilin P; Sumberaz A; Celle G
    Eur J Clin Pharmacol; 1988; 35(2):203-7. PubMed ID: 3191940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
    Netzer P; Eschenmoser K; Halter F; Inauen W
    Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of oral nizatidine.
    Vargas R; Ryan J; McMahon FG; Regel G; Offen WW; Matsumoto C
    J Clin Pharmacol; 1988 Jan; 28(1):71-5. PubMed ID: 2895125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
    Lanzon-Miller S; Pounder RE; Ball SG; Dalgleish DJ; Coward J; Jackson AO
    Scand J Gastroenterol; 1988 Mar; 23(2):244-50. PubMed ID: 3283919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an oral evening dose of nizatidine on nocturnal and peptone-stimulated gastric acid and gastrin secretion.
    Kovacs TO; Van Deventer GM; Maxwell V; Sytnik B; Walsh JH
    Scand J Gastroenterol Suppl; 1987; 136():41-6. PubMed ID: 2892254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.